drug

Support group

Support Group
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
Metacognitive Training and Insight in Schizophrenia
NCT04104347—Unknown
Cognitive Behavior Therapy and Work Outcome
NCT00810355—Completed

KOLs & investigators

2
Paul Lysaker, PhD
Javier-David Lopez-Morinigo, MB BS, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
company
trial
Metacognitive Training and Insight in Schizophrenia
NA
trial
Cognitive Behavior Therapy and Work Outcome
NA
trial
indication
Schizophrenia
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
KOL
Paul Lysaker, PhD
KOL score —
person
Javier-David Lopez-Morinigo, MB BS, PhD
KOL score —
person